Ligand validation:2PD3

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 2PD3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2PD3_NAD_D_4780	61%	24%	0.149	0.938	1.78	1.49	4	7	3	0	100%	1
2PD3_NAD_B_2780	58%	26%	0.158	0.936	1.78	1.4	4	5	4	0	100%	1
2PD3_NAD_A_1780	55%	26%	0.154	0.924	1.78	1.36	3	6	0	0	100%	1
2PD3_NAD_C_3780	47%	27%	0.175	0.915	1.76	1.32	3	4	2	0	100%	1
8JFM_NAD_E_301	92%	49%	0.085	0.975	0.87	1.11	-	5	0	0	100%	1
8JFN_NAD_A_301	84%	18%	0.115	0.979	1.83	1.88	8	6	2	0	100%	1
2PD4_NAD_C_3780	73%	25%	0.125	0.952	1.81	1.38	4	7	3	0	100%	1
4URF_NAD_A_1249	100%	45%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	25%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	11%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068
2JHF_NAD_B_403	100%	18%	0.04	0.99	2.08	1.62	11	5	2	0	100%	1
1HEU_NAD_B_402	100%	8%	0.043	0.993	2.5	2.41	13	11	0	0	100%	0.8886

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.